chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of VAQTA lot # L046953, expiry date 14-JAN-2017, lot # 015460, expiry date 20-JUL-2017, lot # 045713, expiry date 14-JAN-2017, lot # L043209, expiry date 17-SEP-2017 (dose, route and site of administration were not reported). No adverse effect was reported. Administered doses of vaccines experienced the temperature excursion of 0.2 degrees Celsius for 48 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
Exactly 12 days after my vaccine I developed a mild case of depression/anxiety/stress that persists as of this writing There was no other  precipitating event that could have triggered this. I have always been emotionally strong. I have never felt like this in my life. This anxiety/depression caused GI symptoms that I had evaluated.
4 hours after immunizations, delayed breathing. EMS called and hospitalized for 2 days for obstruction.
Severe vomiting, severe diarrhea, nausea, 99.1F temp. - started 03/11/2021 @ 09:00 - dissipated 03/11/2021 @ 16:00 Fatigue- started 03/11/2021 @ 09:00  Wife called primary doctor, doctor said if symptoms do not disappear in 12 hours go to emergency room. Since symptoms dissipated in 5 hours, pt did not go to emergency room.
patient was given this xtra dose by mistake of the kinrix, her brother was getting vaccines also and the ma grabbed the wrong set of shots, the child is fine and has been checked on by the crnp , no adverse reactions
Fever 101.4  headache fatigue chills   Advised continue apap as directed if no resolution of fever greater than 101 degrees seek medical  attention.
6 hours after injection total body muscle aches , tired, followed over next 24 hours by chilling, temp 100.6, nausea (vomited once), headache. Next 12 hours less ache, no fever, headache persists.
Patient received the first Moderna vaccine at nine o'clock Thursday morning, felt fine until 2pm. She began to feel feverish, achy, nauseous, weak.  All symptoms lasted through Sunday when she passed out early in the morning.  We found her on the kitchen floor, having hit her head and bleeding.  She was conscious and alert but a little disoriented and very weak.  We called for an ambulance which took her to the same facility where she had been vaccinated.  She was diagnosed with a concussion and low blood pressure (62/49).   Today she still feels weak and dizzy and nauseous.  She has not returned to work yet, pending recommendation from her cardiologist and PCP.
12-year-old received Infanrix; received Infanrix instead of Boostrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 12-year-old male patient who received DTPa (Infanrix) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 7th September 2021, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 7th September 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: Nurse reported that a 12-year-old patient received Infanrix instead of Boostrix which led to inappropriate age at vaccine administration and wrong vaccine administered. The reporter consented to follow up.
Developed Rosacea 2 weeks after vaccination.  Acne like lesions.  Given a topical RX: Aveidaoxia Gel
Started as what appeared to be a patch of hives on his left shoulder blade. By the next day it was worse and red, looking rash like and by Friday the 15th it covered his entire back and had spread to his chest, stomach, diaper area and legs. Does not appear to bother him. I need to note that my son had a cold prior to immunization and it was his first day of feeling better. He also will NOT eat eggs and when he had twice previously he projectile vomited. I was not asked if he has an egg allergy, nor did I understand that would potentially be an issue.
ADMINISTRATION OF EXPIRED VACCINE 30 MINS AFTER EXPIRATION; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced administration of expired vaccine 30 mins after expiration. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of expired vaccine 30 mins after expiration was not reported. This report was non-serious.
Patient has a history of fainting at needles, and he lost consciousness briefly immediately after injection. When he aroused, the patient said he felt "weird." EMT evaluated patient and administered a cold compress, water, and juice. Patient's uncle drove him home. completed the following: 5/14/21: 12:43pm - TC to mom who reports her son is doing fine. No problems or concerns.
Covid vaccine lot 025L20A Patient reported at her second COVID vaccine shot that her arm swelled down to her elbow and arm had a rash. Patient reports that this lasted 1 week.
Information has been received from a registered nurse concerning a 43 year old male with no pertinent medical history and no drug reactions/allergies on 23-JAN-2009 was vaccinated with the first dose of VARIVAX 0.5ml SQ on the left arm (LOT# 661979/1276X). There was no concomitant medication. On 25-JAN-2009 the patient developed a couple of red raised spots on the left chest. One was about 1 cm and the other was 2 cm. The patient was not recovered from the adverse event. It was reported that the patient sought medical attention: was seen by primary office. Follow up information was received from the registered nurse who reported that the patient on 23-JAN-2009 10:00 AM was vaccinated with the first dose of VARIVAX 0.5 ml SQ on the left arm (LOT# 661979/1276X). On 25-JAN-2009 unspecified time, the patient developed a rash on his abdomen on his left side which was macupapular in nature (2 areas, 1 about 1cm's, 1 about 2cm in diameter) was seen in occupational health. On 30-JAN-2009, the patient came to health service and stated that he received the Chickenpox vaccine Friday 23-JAN and he noticed a rash on his abdomen Sunday 25-JAN-2009. The patient had a varicella titer drawn last week that showed to immunity. So he received the VARIVAX. The patient denied any other symptoms (no fever, pruritis, etc.) other than a rash on his mid anterior and lateral torso. The patient denied using any new products such as clothing, detergents or lotions and can recall no other possible offending agent. No OTC MEDS requested. The patient was advised to use OTC Benadryl or Cortisone oint PRN and the patient stated did not need anything at this time as he only had rash. It was noted by the health professional at this time that the patient had a 2-3 inch area of dry, red raised 1cm spots on mid anterior abdomen and 1 inch area of same on upper left lateral abdomen. No blisters noted. ALT in skin integrity abdomen R/T rash possibly due to recent VARIVAX. Keep areas clean dry. May use OTC Benadryl or Cortisone oint as instructed. The patient was advised to contact HS if rash increased or new symptom occur. On 30-JAN-2009, the patient reported that his rash was the same except for some mild itching at the lateral site. He reported no other symptoms. Rash appeared same excepted lateral site was a fine papular rash. No drainage. Alteration in skin integrity abdomen related to recent VARIVAX? Continued with OTC cortisone oint PRN. Continue with immunizations/travel health. No further information is available.
Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Mild, Systemic: Shakiness-Medium
double vision;dizziness;nausea;fatigue;diarrhea;tx w/rest/phenergan/antivert;
high pitched screaming lasting over 6 hrs; limp, pale; high pitched screaming resumed for several hrs on 16MAR94 doing fine on 17MAR94;
10:20a - Vaccine given    10:25a - 5 minutes after vaccine given c/o lip and tongue "tingling".  Felt lips were "swollen", no visual lip size change noted. 10:28a - 8 minutes after vaccine given, Benadryl 50 mg orally given  10:35a - Patient stated lip & tongue "tingling" resolved.  Observed until 11am and instructed Adult Caregivers to cont. to observe. 1:30p -  Follow up call with the Adult Care Home caregivers, No further symptoms verbalized by patient
No additional adverse events; patient was administered improperly stored VARIVAX; Information has been received from a nurse referring to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported.  On 24-FEB-2020, the patient was administered improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (strength, dose and route were not reported) (lot # S025610, expiration date 18-AUG-2021) for prophylaxis (product storage error). The varicella virus vaccine live (oka/merck) (VARIVAX) was reconstituted with properly stored sterile diluent (STERILE DILUENT).   The improperly varicella virus vaccine live (oka/merck) (VARIVAX) was stored at temperature 6 degrees Fahrenheit to 14 degrees Fahrenheit (8.6 Fahrenheit) for 44 hours and 42 minutes. There was previous temperature excursion: 15 degrees Fahrenheit to 46 degrees Fahrenheit (30.4 Fahrenheit) for 6 hours and 12 minutes; 15 degrees Fahrenheit to 46 degrees Fahrenheit (30.4 Fahrenheit) for 6 hours and 12 minutes; 15 degrees Fahrenheit to 46 degrees Fahrenheit (16 Fahrenheit) for 2 hours and 18 minutes; 6 degrees Fahrenheit to 14 degrees Fahrenheit (11.1 degrees Fahrenheit) for 1 hour; 6 degrees Fahrenheit to 14 degrees Fahrenheit (7.7 Fahrenheit) for 30 minutes; 6 degrees Fahrenheit to 14 degrees Fahrenheit (10.4 Fahrenheit) for 2 hours and 6 minutes; 6 degrees Fahrenheit to 14 degrees Fahrenheit (9.9 Fahrenheit) for 1 hour. The data logger was not involved. No additional adverse event was reported.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-2002USA009560:
allergic reaction; redness came back; (left leg) with a light rash over the whole leg; redness; legs turned pink/red from her knee down to the top of the socks area on both legs/redness came back; rash like bumps, "hundreds of them" under the skin/ (left leg) with a light rash over the whole leg; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (legs turned pink/red from her knee down to the top of the socks area on both legs/redness came back), RASH (rash like bumps, "hundreds of them" under the skin/ (left leg) with a light rash over the whole leg), HYPERSENSITIVITY (allergic reaction), VACCINATION SITE ERYTHEMA (redness) and ERYTHEMA (redness came back) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0481AZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced ERYTHEMA (legs turned pink/red from her knee down to the top of the socks area on both legs/redness came back), RASH (rash like bumps, "hundreds of them" under the skin/ (left leg) with a light rash over the whole leg), VACCINATION SITE ERYTHEMA (redness) and RASH ((left leg) with a light rash over the whole leg). On 10-Apr-2021, the patient experienced HYPERSENSITIVITY (allergic reaction) and ERYTHEMA (redness came back). At the time of the report, ERYTHEMA (legs turned pink/red from her knee down to the top of the socks area on both legs/redness came back), RASH (rash like bumps, "hundreds of them" under the skin/ (left leg) with a light rash over the whole leg), HYPERSENSITIVITY (allergic reaction), VACCINATION SITE ERYTHEMA (redness), ERYTHEMA (redness came back) and RASH ((left leg) with a light rash over the whole leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.
Shaking/temors, numbness of right side, face drooping, sour of speech, stroke/seizure like symptoms.
First reaction I had, I noticed about 2 hours after shot I had hives around my knees and above my thighs size larger than an index card not as large as sheet a paper. Then I felt my throat was a little scratchy, very similar to allergic reactions I have. I took Benadryl. The next day I was ok then felt off so I took Benadryl again. I was fine 48 hours. Then in July four months later, I woke up I thought had indigestion and it continued to slowly get worse over the day and by 5 0'clock, I started getting breathless, I felt heaviness across my chest and shoulders, I try to go to sleep and I'm not comfortable lying down. At 6 o'clock in the morning woke up my daughter to take me to the hospital, we got to hospital they did an EKG, some kind of heart enzymes were elevated and echocardiogram and they felt like it was myocarditis. Wednesday they did an angiogram and they said my arteries looked great. Meanwhile I had pulmonary embolisms which they think were caused by my long flight and they did a CT scan. They told me just to rest and take it easy until I feel better and they put me on blood thinners for the pulmonary embolism.
Patient received a dose of FLUAD 65+ on 10/19/23 .  This was a duplicate.  He had already received a dose.   Patient had no issues with 2nd dose.
Syncopy after TDap and HPV vaccines. Pt seated, evaluated by FNP. Pt quickly regained consciousness. Left clinic with mom 15 minutes later asymptomatic.
nose bleeding; This is a spontaneous report received from a contactable consumer (patient) via Pfizer-sponsored program. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 17Feb2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient reported that he got the 1st dose of Covid 19 Vaccine last 17Feb and the day after that, he got nose bleeding (18Feb2021). The clinical outcome of event was unknown.  Follow-up attempts completed. No further information expected.
3 PM - Rash on face and neck. 430 P - Rash to chest, abdomen and scalp. Lg. hives (silver dollar) size. Consulted with N.P. BENADRYL 50mg PO at 630 P, 11 PM and 630 AM (2-11-14). Rash gone but still itchy.
Patient received PREVNAR 13 one year ago with no issues. The day after she received this vaccine her arm muscle was really sore, with a little swelling, and slightly warm around vaccine site. Doctor confirmed possible adverse reaction to vaccine. Patient also suffered from diarrhea, stomach upset, and feeling fluish shortly after vaccination. Doctor recommended for patient to take BENADRYL.
About 10 to 12 minutes after the injection, I started feeling like my throat was constricted.  I felt pain in my temple and I also felt like my ears were clogged.  My tonugue was tingling and I had pain across my chest.   I had trouble swallowing and taking a deep breath.  The medical providers assessed me and since my heart was not racing and I did not have a rash all over my body, deemed I was okay.  When I went home, I noticed a rash on my chest from my collarbone to my sternum and alongside my ears on my neck.  My sister is an ER Doctor and I did a video conference with her. She had me take Benadryl.  I have never had any reaction to any vaccine nor have I ever had to take Benadryl.
Pfizer COVID vac #1 given on 2/10/21, lot # EL3246; Pfizer COVID vac #2 given on 3/3/21, lot #EN5318; pt had a positive COVID home test 3 days before coming to ED; 2/3/22 pt presents to ED with SOB the night before, decreased UOP, even though drinking the same amount of fluids, fever, non-productive cough, dyspnea; admitted; 2/4/22 positive COVID test; acute on chronic renal failure; at first, did not need O2 supplementation, but later needed O2 was required; code blue called due to pt being unresponsive and pulseless, asystole; CPR and ACLS protocol; intubated; remained asystole and pt expired in the hospital
This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HYPOAESTHESIA ORAL (Numbness on the lower lip) and HEADACHE (Little headache) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and METOPROLOL.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced HYPOAESTHESIA ORAL (Numbness on the lower lip) and HEADACHE (Little headache). At the time of the report, HYPOAESTHESIA ORAL (Numbness on the lower lip) and HEADACHE (Little headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment was reported
Patient came in a few days after receiving immunization with a large red lump on arm where the shot was administered. He said there was a little bit of pain and itching but not too much. He stated that the reaction occurred almost immediately after administration and that it has slowly been getting better over the last few days.
Initial report was received 17 December 2010 from a health consumer, who is also the patient. A 49-year-old female patient had received an intramuscular injection of FLUZONE, lot number UT3568BA on 12 October 2010 and three and a half hours later, she experienced a racing heart, burning throat and her face and ears were red. She had no illness at the time of vaccination and she had been taking TOPROL XL and Amaprozol concomitantly. Her past medical history included Penicillin and seasonal allergies. The event did not require a doctor's visit and outcome was reported as recovered. The patient had previously experienced a similar event following a flu vaccination 10 years ago. Follow-up information was received from the patient on 31 January 2011. The patient was taking omeprazole concomitantly (previously reported as "amaprazol"). Significant past medical history included hypertension and gastroesophageal reflux disease (GERD). The symptoms persisted for approximately 18 hours, and resolved on 13 October 2010. The patient did not seek treatment for the symptoms. No additional information was available. Documents held by sender: None.
Information has been received from a registered nurse (R.N.) concerning that during the past few months a few patient who were vaccinated with a second dose of VARIVAX (Merck) (lot number, injection site and route not reported).  Subsequently the patients experienced generalized rashes.  One patient had cellulitis and was treated with an unnamed antibiotic.  Unspecified medical attention was sought for these events.  All children were about 4 years old.  Follow-up information was received from the R.N. on 07-JUL-2008 concerning a 17 year old female student with asthma and no known allergies who on 18-OCT-2001 and 14-MAY-2008 was vaccinated subcutaneously in the left arm with first and second 0.5ml doses, respectively, of VARIVAX (Merck) (Lot number of second dose 659357/1567U, expiration date 28-SEP-2009).  Concomitant medication included ALBUTEROL.  On 15-MAY-2008 the patient developed arm redness and warmth to touch.  On 17-MAY-2008 the patient developed red, raised and itchy rash which was about palm size.  On 18-MAY-2008 the patient developed left upper arm induration and was seen in office.  The patient was treated with KEFLEX.  Subsequently the patient recovered from the events.  Follow-up information was received via telephone call or 21-JUL-2008 from a nurse.  She reported that the patient recovered from all adverse events reported.  This is one of several reports from the same source.  Additional information is not expected.
accidental overdose, inject site soreness & tiredness; pt was not receiving any other meds; pt recvd flu vax 10OCT93 recvd 5ml instead of 0.5ml;
Raised, red, itchy, severe rash on left side of body. Most intense on left leg. No reaction at vaccination site. Developed moderate to severe tinnitus in my left ear. Also seem to be having mild balance issues.
Patient was given 1 dose of  moderna 02.16.21 and received 1 dose of pfizer 4.20.21
Chills on evening of day 1, and then injection site redness on day 9 (1/5/21) Narrative: Patient used over the counter tylenol to treat event (unclear whether it was on day 1 or day 9 of injection)
Mild symptoms including chills, headache, fatigue, arm soreness more intense than first shot (but no problems with mobility).
felt weak.; diagnosed with an UTI; high fevers; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (felt weak.), URINARY TRACT INFECTION (diagnosed with an UTI) and PYREXIA (high fevers) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced ASTHENIA (felt weak.), URINARY TRACT INFECTION (diagnosed with an UTI) and PYREXIA (high fevers). The patient was treated with FLUCONAZOLE ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, ASTHENIA (felt weak.), URINARY TRACT INFECTION (diagnosed with an UTI) and PYREXIA (high fevers) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.
pt recv vax 23AUG96 & had t105, cough, anorexia, rt infiltrate on CXR, pt 32wk premature;
No adverse effects; patient was administered an improperly stored dose of PROQUAD; This spontaneous report was received from a nurse and refers to a patient of an unknown gender and age.  No information regarding drug reactions, allergies or medical history were reported.   On 26-JUL-2019, the patient was vaccinated with an improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot #R023500, expiration date: 13-FEB-2020, therapy type: rha) (dose and route of administration was not provided) for prophylaxis. The vaccine underwent temperature excursion of -12.7 degrees Celsius; time frame was 58 minutes. There was no previous temperature excursion. Concomitant therapies included sterile diluent. The sterile diluent was properly stored. There was no adverse effect reported. The call was made because of a digital data logger.  This is 1 of 2 reports received from the same reporter.; Sender's Comments:  US-009507513-1908USA000135: